St. Peters, MO, United States of America

David W Berberich

USPTO Granted Patents = 28 

 

 

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 85(Granted Patents)


Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

Title: David W. Berberich: Innovator in Pain Management

Introduction

David W. Berberich, an accomplished inventor based in St. Peters, MO, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 28 patents, his work focuses primarily on innovative solutions for pain management through novel compounds.

Latest Patents

Among his latest inventions are two notable patents involving (+)-morphinans as antagonists of Toll-like receptor 9 (TLR9). The first patent details the use of these compounds to treat pain, showcasing their antagonist activity against TLR9. It also describes pharmaceutical combination compositions that include a (+)-morphinan alongside an opioid agonist or monoamine reuptake inhibitor for effective pain treatment. The second patent expands on the therapeutic applications of (+)-morphinans in addressing various disorders, highlighting their potential in the pharmaceutical industry.

Career Highlights

David W. Berberich is currently employed at Mallinckrodt, Inc., where he continues to innovate in the realm of pain management therapies. His extensive work and research in drug development have positioned him as a leader in creating effective therapeutic options.

Collaborations

Throughout his career, Berberich has collaborated with notable professionals in his field, including Peter Xianqi Wang and Gary Lee Cantrell. These partnerships have undoubtedly contributed to the advancement of his research and the successful development of his patents.

Conclusion

David W. Berberich's expertise and dedication to innovation in pharmacology have resulted in significant advancements that address pain management and related disorders. His ongoing work at Mallinckrodt, Inc., along with his impressive patent portfolio, underscores his impact on the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…